In an online Science Café, Professor Kyle Biggar from the Biggar lab. Discusses how his lab has already developed a promising new inhibitor, of the KDM5C enzyme as a therapeutic target for cancer treatment.
Cancer is caused by unregulated cellular growth, leading to catastrophic consequences for the tissues and organs in which these cells uncontrollably multiply. Research over the past 15+ years has revealed that gene mutation and expression changes underlie the onset, progression, and therapeutic resistance of cancer.